Aligos Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Aligos Therapeutics

04/05/2024 03:02

* Aligos Therapeutics Inc  ALGS.OQ   ALGS.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 7 for
the period ending January 1 0001
    * 
    * ​LSEG's mean analyst estimate for Aligos Therapeutics Inc
is for
a loss of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 3.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Aligos
Therapeutics Inc is $4.00​, above​ its last closing price
of $0.81. ​​​

This summary was machine generated May 4 at 02:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)